Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.

摘要: Pharmacogenetic (PGx) testing aims to improve therapeutic outcomes through tailoring treatment based on a patient's genetic risk for non-response and/or an adverse event. Given their expertise, geneticists could facilitate the use of PGx testing; however, preparedness and perceived role clinical genetics community is unclear. To assess attitudes, preparedness, roles in delivery testing, we conducted survey 1500 randomly selected board-certified counselors United States [response rate: 37.8% (n = 516)]. Twelve percent 41% indicated that they had ordered or coordinated patient care seemingly high proportion at this early stage adoption. Almost all respondents some education pharmacogenetics, although only 28% 58% felt well-informed about testing. About half (52%) (46%) would play 'some' 17 19%, respectively, 'no' 'a little' role. At However, experience may aid readying informing strategies into practice.